<DOC>
	<DOCNO>NCT00004772</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare response previously untreated patient chronic inflammatory demyelinate polyneuropathy intravenous immune globulin vs. placebo .</brief_summary>
	<brief_title>Phase III Randomized , Double-Blind , Placebo-Controlled Study Intravenous Immune Globulin Chronic Inflammatory Demyelinating Polyneuropathy</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double-blind study . The first group receive intravenous immune globulin ( IVIG ) day 1 , 2 , 21 ; second group receive intravenous placebo schedule . Patients either group may receive IVIG ( dosage first group ) day 42 . Concurrent steroid immune globulin preparation prohibit .</detailed_description>
	<mesh_term>Polyradiculoneuropathy , Chronic Inflammatory Demyelinating</mesh_term>
	<mesh_term>Polyradiculoneuropathy</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Chronic inflammatory demyelinate polyneuropathy ( CIDP ) , i.e . : Progressive relapse motor sensory dysfunction 1 limb least 2 month Hypo areflexia least 2 limbs No myelopathy No central demyelination No drug toxic exposure know cause peripheral neuropathy Prior/Concurrent Therapy No prior corticosteroid immunomodulators CIDP No prior plasmapheresis At least 30 day since participation investigational study At least 6 month since follow : Cyclophosphamide Intravenous immune globulin Cyclosporine Interferon alfa Azathioprine Corticosteroids Orthoclone Tacrolimus Patient Characteristics Hepatic : No hepatitis Renal : Not specify Neurologic : Cerebrospinal fluid ( CSF ) protein great 50 mg/dL CSF cell count le 10 CSF VDRL negative 3 follow motor abnormality electrophysiology : Reduced conduction velocity 2 motor nerve Less 80 % normal amplitude great 80 % normal Less 70 % normal amplitude le 80 % normal Conduction block abnormal temporal dispersion 1 motor nerve No ulnar peroneal nerve entrapment Prolonged distal latency 2 nerve Greater 125 % normal amplitude great 80 % normal Greater 150 % normal amplitude le 80 % normal Absent Fwaves H response ( patient age 60 ) prolong short Fwave latency 10 15 trial 2 motor nerve Other : No hypersensitivity immune globulin No IgA deficiency No mutilation hand foot No retinitis pigmentosa No ichthyosis No disease would limit neuromuscular assessment No endocrinopathy No connective tissue disease vasculitis No Lyme disease No malignancy No Castleman 's disease No hyper hypothyroidism No HIV infection No alcohol drug abuse No pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2001</verification_date>
	<keyword>demyelinate neuropathy</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>